683699

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 683699, covering 2015-04-13 to 2015-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease [Phase 2]